Fracture in Asian Women with Breast Cancer Occurs at Younger Age

被引:11
作者
Tsa, Chun-Hao [1 ,2 ]
Muo, Chih-Hsin [3 ,4 ]
Tzeng, Huey-En [1 ,5 ]
Tang, Chih-Hsin [2 ,6 ]
Hsu, Horng-Chang [1 ,2 ]
Sung, Fung-Chang [3 ,4 ]
机构
[1] China Med Univ, Grad Inst Med, Taichung, Taiwan
[2] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan
[3] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[4] China Med Univ, Dept Publ Hlth, Taichung, Taiwan
[5] Taichung Vet Gen Hosp, Div Hematol Oncol, Taichung, Taiwan
[6] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan
关键词
BONE-MINERAL DENSITY; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OSTEOPOROTIC FRACTURES; ADJUVANT CHEMOTHERAPY; INTERGROUP EXEMESTANE; EARLY MENOPAUSE; OLDER WOMEN;
D O I
10.1371/journal.pone.0075109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast cancer occurs 10 to 20 years earlier in Asian women than in Western women. We investigated if younger Asian women with breast cancer also have increased risk of fracture. Methods: We used the universal insurance claims data from 2000 to 2003 to identify 22,076 patients with breast cancer and 88,304 women without cancer, frequency matched with age and index date (the date for a health care visit). The incidence of fracture in both cohorts and the hazard ratios (HRs) of fracture in the cancer cohort were estimated by the end of 2009. Results: The incidence of all types of fracture was higher in the breast cancer cohort than in the comparison cohort (46.72 vs. 42.52 per 10,000 person-years), with adjusted HRs (aHRs) of 1.18 (95% confidence intervals [CI], 1.03-1.35) for hip fractures, 1.12 (95% CI, 0.98-1.28) for forearm fractures and 1.24 (95% CI, 1.04-1.48) for vertebral fractures. The aHRs were significant in both non-traumatic fractures (1.29; 95% CI, 1.11-1.51) and traumatic fractures (1.12; 95% CI, 1.01-1.23). The age-specific aHR was higher for younger breast cancer patients, and was significant for,50 years old patients in both traumatic (aHR 1.35; 95% CI 1.08-1.68) and non-traumatic (aHR, 1.72; 95% CI, 1.21-2.44) fractures. Conclusion: This study suggests that Asian women with breast cancer might have an increased risk of fracture.
引用
收藏
页数:6
相关论文
共 42 条
[1]   Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women [J].
Adami, Silvano ;
Zivelonghi, Alessandra ;
Braga, Vania ;
Fracassi, Elena ;
Gatti, Davide ;
Rossini, Maurizio ;
Ulivieri, Fabio M. ;
Viapiana, Ombretta .
BONE, 2010, 46 (01) :244-247
[2]   Breast Cancer Issues in Developing Countries: An Overview of the Breast Health Global Initiative [J].
Anderson, Benjamin O. ;
Jakesz, Raimund .
WORLD JOURNAL OF SURGERY, 2008, 32 (12) :2578-2585
[3]  
[Anonymous], 1997, OSTEOPOROS INT S3, V7, P1
[5]   Bone mineral density and risk of breast cancer in older women - The study of osteoporotic fractures [J].
Cauley, JA ;
Lucas, FL ;
Kuller, LH ;
Vogt, MT ;
Browner, WS ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17) :1404-1408
[6]   Defining Ethnic and Racial Differences in Osteoporosis and Fragility Fractures [J].
Cauley, Jane A. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (07) :1891-1899
[7]   Fracture risk among breast cancer survivors - Results from the Women's Health Initiative Observational Study [J].
Chen, Z ;
Maricic, M ;
Bassford, TL ;
Pettinger, M ;
Ritenbaugh, C ;
Lopez, AM ;
Barad, DH ;
Gass, M ;
LeBoff, MS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (05) :552-558
[8]   Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study [J].
Coleman, Robert E. ;
Banks, Linda M. ;
Girgis, Samia I. ;
Kilburn, Lucy S. ;
Vrdoljak, Eduard ;
Fox, John ;
Cawthorn, Simon J. ;
Patel, Ashraf ;
Snowdon, Claire F. ;
Hall, Emma ;
Bliss, Judith M. ;
Coombes, R. Charles .
LANCET ONCOLOGY, 2007, 8 (02) :119-127
[9]   Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study [J].
Coleman, Robert E. ;
Banks, Linda M. ;
Girgis, Samia I. ;
Vrdoljak, Eduard ;
Fox, John ;
Cawthorn, Simon J. ;
Patel, Ashraf ;
Bliss, Judith M. ;
Coombes, R. Charles ;
Kilburn, Lucy S. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) :153-161
[10]   Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial [J].
Cuzick, Jack ;
Sestak, Ivana ;
Baum, Michael ;
Buzdar, Aman ;
Howell, Anthony ;
Dowsett, Mitch ;
Forbes, John F. .
LANCET ONCOLOGY, 2010, 11 (12) :1135-1141